Home LiteratureArticle Details
PMID: 18997494 Published · ppublish English Journal Article Review

The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.

Journal of endocrinological investigation ·Vol. 31 ·No. 9 ·2008-09-00 ·Pages 809-19

Gelmini S, Mangoni M, Serio M, Romagnani P, Lazzeri E

Abstract

Chemokines exert their multifunctional role in several physiologic and pathologic processes through interaction with their specific receptors. Much evidence have revealed that metastatic spread tumor cells may use chemokine-mediated mechanisms. In particular, an involvement of stromal cell-derived factor-1 (SDF-1) in growth of primary tumors and in metastatic process has been demonstrated. Indeed, it has been suggested that CXCR4 expression by tumor cells, plays a critical role in cell metastasis by a chemotactic gradient to organs expressing the ligand SDF-1. Moreover, CXCR4 overexpression correlated with poor prognosis in many types of cancer. In physiologic condition, SDF-1 also plays an essential role modulating stem cell proliferation, survival, and homing through its canonical receptor CXCR4. Recently, several studies have demonstrated the existence of a small subset of cancer cells which share many characteristics with stem cells and named cancer stem cells (CSC). They constitute a reservoir of self-sustaining cells with the ability to maintain the tumor growth. In particular, most of them express CXCR4 receptor and respond to a chemotactic gradient of its specific ligand SDF-1, suggesting that CSC probably represent a subpopulation capable of initiating metastasis. This review focuses on the role of SDF-1/CXCR4 axis in cancer and in the metastatic progression by tumoral cells, as well as the role of CSC in tumor pathogenesis and in metastatic process. A better understanding of migratory mechanism involving cancer cells and CSC provides a powerful tool for developing novel therapies reducing both local and distant recurrences.

MeSH Terms
Chemokine CXCL12/metabolism Humans Neoplasm Metastasis Neoplasms/metabolism,pathology Neoplastic Stem Cells/metabolism,pathology Receptors, CXCR4/metabolism
Chemicals
Chemokine CXCL12 Receptors, CXCR4
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gelmini S
Clinical Biochemistry Unit, Department of Clinical Pathophysiology, University of Florence, Florence, Italy.
Mangoni M
Serio M
Romagnani P
Lazzeri E
References (177)
177 references, click to expand
  1. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.
    Exp Hematol. 2002 Sep;30(9):973-81 PMID: 12225788
  2. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    J Clin Oncol. 2005 Apr 20;23(12):2744-53 PMID: 15837989
  3. Chemokine signaling: rules of attraction.
    Curr Biol. 2003 Mar 4;13(5):R192-4 PMID: 12620211
  4. Chemokine receptors.
    Cytokine Growth Factor Rev. 2001 Dec;12(4):313-35 PMID: 11544102
  5. A self-renewal assay for cancer stem cells.
    Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:64-8 PMID: 16273355
  6. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
    Am J Respir Crit Care Med. 2003 Jun 15;167(12):1676-86 PMID: 12626353
  7. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.
    Nat Med. 2004 Aug;10(8):858-64 PMID: 15235597
  8. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
    Lab Invest. 2004 Dec;84(12):1666-76 PMID: 15467730
  9. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.
    Cell. 2006 Jan 27;124(2):407-21 PMID: 16439213
  10. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.
    Science. 1992 Feb 28;255(5048):1137-41 PMID: 1372131
  11. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
    Prostate. 2007 Jan 1;67(1):61-73 PMID: 17034033
  12. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
    Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15735-40 PMID: 17898181
  13. The significance of cancer cell expression of the chemokine receptor CXCR4.
    Semin Cancer Biol. 2004 Jun;14(3):171-9 PMID: 15246052
  14. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Cancer Res. 2003 Nov 15;63(22):7926-35 PMID: 14633723
  15. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.
    Clin Immunol. 2003 Oct;109(1):89-102 PMID: 14585280
  16. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development.
    Br J Cancer. 2003 Nov 17;89(10):1817-21 PMID: 14612884
  17. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
    Cancer Res. 2006 Oct 1;66(19):9339-44 PMID: 16990346
  18. General mechanisms of metastasis.
    Cancer. 1997 Oct 15;80(8 Suppl):1529-37 PMID: 9362419
  19. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Eur J Haematol. 2005 Dec;75(6):461-7 PMID: 16313257
  20. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.
    Blood. 2001 Jun 1;97(11):3354-60 PMID: 11369624
  21. Cancer stem cell hypothesis in thyroid cancer.
    Pathol Int. 2006 Sep;56(9):485-9 PMID: 16930327
  22. Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function.
    J Mol Endocrinol. 2007 Mar;38(3):383-9 PMID: 17339401
  23. Applying the principles of stem-cell biology to cancer.
    Nat Rev Cancer. 2003 Dec;3(12):895-902 PMID: 14737120
  24. Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis.
    Breast Cancer Res. 2006;8(5):109 PMID: 16934104
  25. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
    Science. 1999 Feb 5;283(5403):845-8 PMID: 9933168
  26. Immune evasion by murine melanoma mediated through CC chemokine receptor-10.
    J Exp Med. 2003 Nov 3;198(9):1337-47 PMID: 14581607
  27. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
    N Engl J Med. 2004 Jun 3;350(23 ):2335-42 PMID: 15175435
  28. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.
    Blood. 2004 Jul 15;104(2):550-7 PMID: 15054042
  29. Modulation of hematopoietic stem cell homing and engraftment by CD26.
    Science. 2004 Aug 13;305(5686):1000-3 PMID: 15310902
  30. Circulating osteoblast-lineage cells.
    N Engl J Med. 2005 Aug 18;353(7):737-8; author reply 737-8 PMID: 16107631
  31. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
    BMC Cancer. 2006 Dec 18;6:290 PMID: 17176471
  32. The chemokine SDF1 regulates migration of dentate granule cells.
    Development. 2002 Sep;129(18):4249-60 PMID: 12183377
  33. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.
    Blood. 2000 Jun 1;95(11):3289-96 PMID: 10828007
  34. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
    Cancer Res. 2005 Jun 15;65(12):5084-95 PMID: 15958552
  35. Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals.
    Mol Pharmacol. 2006 Feb;69(2):539-46 PMID: 16258074
  36. Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates.
    Curr Med Chem. 2007;14(21):2257-77 PMID: 17896975
  37. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Cancer Res. 2005 Jul 15;65(14 ):6207-19 PMID: 16024622
  38. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.
    Mod Pathol. 2006 May;19(5):738-45 PMID: 16528367
  39. Cancer CXC chemokine networks and tumour angiogenesis.
    Eur J Cancer. 2006 Apr;42(6):768-78 PMID: 16510280
  40. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Stem Cells. 2005 Aug;23(7):879-94 PMID: 15888687
  41. A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
    Semin Oncol. 2003 Oct;30(5 Suppl 16):117-24 PMID: 14613032
  42. Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury.
    J Immunol. 2006 Feb 1;176(3):1916-27 PMID: 16424223
  43. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.
    Cell. 2006 Jan 13;124(1):175-89 PMID: 16413490
  44. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    FASEB J. 2004 Aug;18(11):1240-2 PMID: 15180966
  45. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
    J Clin Invest. 2005 Apr;115(4):959-68 PMID: 15776112
  46. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
    Nature. 1994 Feb 17;367(6464):645-8 PMID: 7509044
  47. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
    J Exp Med. 2006 Sep 4;203(9):2201-13 PMID: 16940167
  48. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
    J Immunol. 2001 Oct 15;167(8):4747-57 PMID: 11591806
  49. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.
    Oncol Rep. 2007 Jun;17(6):1511-6 PMID: 17487412
  50. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    J Biol Chem. 2003 Jun 13;278(24):21631-8 PMID: 12690099
  51. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Mol Endocrinol. 2003 May;17(5):792-803 PMID: 12586845
  52. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice.
    Blood. 2002 Feb 1;99(3):792-9 PMID: 11806978
  53. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Int J Cancer. 2008 Jan 1;122(1):91-9 PMID: 17893878
  54. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Neurosurgery. 2007 Sep;61(3):570-8; discussion 578-9 PMID: 17881971
  55. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.
    Cancer Res. 2003 Aug 15;63(16):4801-4 PMID: 12941798
  56. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
    Cancer Res. 2003 Oct 15;63(20):6751-7 PMID: 14583470
  57. Immunosuppressive networks in the tumour environment and their therapeutic relevance.
    Nat Rev Cancer. 2005 Apr;5(4):263-74 PMID: 15776005
  58. Fibroblasts in cancer.
    Nat Rev Cancer. 2006 May;6(5):392-401 PMID: 16572188
  59. Identification of bronchioalveolar stem cells in normal lung and lung cancer.
    Cell. 2005 Jun 17;121(6):823-35 PMID: 15960971
  60. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    Nature. 2007 Jan 4;445(7123):106-10 PMID: 17122772
  61. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
    Ann Oncol. 2004 Apr;15(4):613-7 PMID: 15033669
  62. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.
    Stem Cells. 2002;20(3):259-66 PMID: 12004084
  63. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Hepatology. 2006 Jul;44(1):240-51 PMID: 16799977
  64. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
    Nature. 2005 Dec 8;438(7069):820-7 PMID: 16341007
  65. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells.
    FEBS Lett. 2007 Apr 3;581(7):1441-8 PMID: 17362937
  66. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.
    Kidney Int. 2005 May;67(5):1772-84 PMID: 15840024
  67. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.
    Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95 PMID: 16943240
  68. Cancerous stem cells can arise from pediatric brain tumors.
    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 PMID: 14645703
  69. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction.
    Circ Res. 2004 Dec 10;95(12):1191-9 PMID: 15550692
  70. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
    Cancer Res. 2004 Apr 15;64(8):2817-24 PMID: 15087398
  71. Clinical significance of CXCR3 and CXCR4 expression in primary melanoma.
    Int J Cancer. 2005 Dec 10;117(5):861-5 PMID: 15981210
  72. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury.
    Blood Cells Mol Dis. 2004 Jan-Feb;32(1):52-7 PMID: 14757413
  73. Niche-to-niche migration of bone-marrow-derived cells.
    Trends Mol Med. 2007 Feb;13(2):72-81 PMID: 17197241
  74. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.
    Stem Cells. 2001;19(5):453-66 PMID: 11553854
  75. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
    J Biol Chem. 2008 Feb 15;283(7):4283-94 PMID: 18057003
  76. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis.
    Oncogene. 2006 Aug 17;25(36):4986-97 PMID: 16568088
  77. CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis).
    Br J Haematol. 2003 Aug;122(4):579-89 PMID: 12899713
  78. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.
    Cancer Res. 2005 Aug 1;65(15):6493-7 PMID: 16061624
  79. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.
    Biochem Pharmacol. 2004 Sep 15;68(6):971-80 PMID: 15313390
  80. Bone marrow-derived stem cells initiate pancreatic regeneration.
    Nat Biotechnol. 2003 Jul;21(7):763-70 PMID: 12819790
  81. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.
    Immunity. 1999 Apr;10(4):463-71 PMID: 10229189
  82. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.
    Circulation. 2004 Nov 16;110(20):3213-20 PMID: 15533859
  83. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    J Bone Miner Res. 2005 Feb;20(2):318-29 PMID: 15647826
  84. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
    Nat Immunol. 2002 Jul;3(7):687-94 PMID: 12068293
  85. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
    Cancer Res. 2007 Dec 15;67(24):11821-9 PMID: 18089812
  86. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Life Sci. 2006 Mar 13;78(16):1784-93 PMID: 16263140
  87. Epithelial cancer cell migration: a role for chemokine receptors?
    Cancer Res. 2001 Jul 1;61(13):4961-5 PMID: 11431324
  88. Cancer stem cells in nervous system tumors.
    Oncogene. 2004 Sep 20;23(43):7267-73 PMID: 15378086
  89. Prospective identification of tumorigenic prostate cancer stem cells.
    Cancer Res. 2005 Dec 1;65(23 ):10946-51 PMID: 16322242
  90. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo.
    J Immunol. 2003 Jan 1;170(1):421-9 PMID: 12496427
  91. Role of HER2/neu in tumor progression and therapy.
    Cell Mol Life Sci. 2004 Dec;61(23):2965-78 PMID: 15583858
  92. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.
    Blood. 2003 Oct 15;102(8):2728-30 PMID: 12855591
  93. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.
    J Clin Invest. 1999 Nov;104(9):1199-211 PMID: 10545519
  94. Organ selectivity in metastasis: regulation by chemokines and their receptors.
    Clin Exp Metastasis. 2008;25(4):345-56 PMID: 17891505
  95. Contiguous binding of decylsulfate on the interface-binding surface of pancreatic phospholipase A2.
    Biochemistry. 2008 Mar 4;47(9):2899-907 PMID: 18260608
  96. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
    Exp Hematol. 2001 Dec;29(12):1439-47 PMID: 11750103
  97. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.
    Ann Oncol. 2007 Jan;18(1):70-6 PMID: 17032700
  98. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells.
    Biol Cell. 2005 Feb;97(2):133-46 PMID: 15656779
  99. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.
    Neoplasia. 2006 Apr;8(4):290-301 PMID: 16756721
  100. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue.
    Cancer Res. 1987 Nov 1;47(21):5748-51 PMID: 3664479
  101. Involvement of chemokine receptors in breast cancer metastasis.
    Nature. 2001 Mar 1;410(6824):50-6 PMID: 11242036
  102. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively.
    Endocrinology. 2007 Apr;148(4):1797-803 PMID: 17234707
  103. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines.
    Exp Hematol. 2000 Nov;28(11):1274-85 PMID: 11063876
  104. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
    Breast Cancer Res. 2003;5(5):R144-50 PMID: 12927045
  105. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
    Cancer Sci. 2007 Nov;98(11):1652-8 PMID: 17894551
  106. High-resolution melting for accurate assessment of DNA methylation.
    Clin Chem. 2007 Nov;53(11):1877-8 PMID: 17954495
  107. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.
    J Exp Med. 2008 Feb 18;205(2):479-90 PMID: 18268039
  108. New signals from the invasive front.
    Nature. 2006 May 25;441(7092):444-50 PMID: 16724056
  109. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
    Eur J Cancer Prev. 2007 Oct;16(5):430-5 PMID: 17923814
  110. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Clin Cancer Res. 2005 Apr 15;11(8):2937-46 PMID: 15837745
  111. Identification of a cancer stem cell in human brain tumors.
    Cancer Res. 2003 Sep 15;63(18):5821-8 PMID: 14522905
  112. Untangling the ErbB signalling network.
    Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37 PMID: 11252954
  113. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.
    Ann N Y Acad Sci. 2004 Dec;1030:162-9 PMID: 15659794
  114. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
    Blood. 2002 Oct 1;100(7):2597-606 PMID: 12239174
  115. Chemokines in tumor progression and metastasis.
    Cancer Sci. 2005 Jun;96(6):317-22 PMID: 15958053
  116. Identification of human brain tumour initiating cells.
    Nature. 2004 Nov 18;432(7015):396-401 PMID: 15549107
  117. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Am J Pathol. 1999 Apr;154(4):1125-35 PMID: 10233851
  118. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Oncogene. 2004 Aug 5;23(35):5958-67 PMID: 15184868
  119. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
    N Engl J Med. 2003 Jul 31;349(5):427-34 PMID: 12890841
  120. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
    Cancer Res. 2004 Oct 1;64(19):7011-21 PMID: 15466194
  121. 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment.
    Mol Pharmacol. 2008 Jan;73(1):191-202 PMID: 17959712
  122. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells.
    Leukemia. 2005 Jul;19(7):1118-27 PMID: 15902288
  123. Stem cells in normal breast development and breast cancer.
    Cell Prolif. 2003 Oct;36 Suppl 1:59-72 PMID: 14521516
  124. Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke.
    Leukemia. 2006 Jan;20(1):18-28 PMID: 16270036
  125. Dissociation between steroid receptor expression and cell proliferation in the human breast.
    Cancer Res. 1997 Nov 15;57(22):4987-91 PMID: 9371488
  126. Bone marrow as a potential source of hepatic oval cells.
    Science. 1999 May 14;284(5417):1168-70 PMID: 10325227
  127. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
    Cancer Res. 2003 Jul 1;63(13):3833-9 PMID: 12839981
  128. The role of Osteopontin in tumor metastasis.
    J Surg Res. 2004 Oct;121(2):228-41 PMID: 15501463
  129. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.
    Cancer Res. 2005 Aug 15;65(16):7086-90 PMID: 16103056
  130. Normal stem cells and cancer stem cells: the niche matters.
    Cancer Res. 2006 May 1;66(9):4553-7 PMID: 16651403
  131. HIV entry inhibitors.
    Lancet. 2007 Jul 7;370(9581):81-8 PMID: 17617275
  132. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.
    Cancer Cell. 2004 Jul;6(1):33-43 PMID: 15261140
  133. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Oncogene. 2005 Jun 23;24(27):4462-71 PMID: 15806155
  134. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
    Nature. 1998 Jun 11;393(6685):595-9 PMID: 9634238
  135. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.
    J Clin Oncol. 2003 Jan 1;21(1):60-5 PMID: 12506171
  136. Adult stem cells for tissue repair - a new therapeutic concept?
    N Engl J Med. 2003 Aug 7;349(6):570-82 PMID: 12904523
  137. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.
    Proc Natl Acad Sci U S A. 2005 May 17;102(20):7180-5 PMID: 15899981
  138. Stem cells, cancer, and cancer stem cells.
    Nature. 2001 Nov 1;414(6859):105-11 PMID: 11689955
  139. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Cancer Res. 2005 Jul 1;65(13):5864-71 PMID: 15994964
  140. Histone deacetylase inhibitors: from target to clinical trials.
    Expert Opin Investig Drugs. 2002 Dec;11(12):1695-713 PMID: 12457432
  141. Identification and expansion of human colon-cancer-initiating cells.
    Nature. 2007 Jan 4;445(7123):111-5 PMID: 17122771
  142. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells.
    Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14470-5 PMID: 10588729
  143. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
    J Clin Oncol. 2004 Mar 15;22(6):1095-102 PMID: 15020611
  144. Circulating myogenic progenitors and muscle repair.
    Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):632-40 PMID: 16087371
  145. Regulation of the chemokine receptor CXCR4 by hypoxia.
    J Exp Med. 2003 Nov 3;198(9):1391-402 PMID: 14597738
  146. EGF receptor in neoplasia and metastasis.
    Cancer Metastasis Rev. 1993 Sep;12(3-4):255-74 PMID: 8281612
  147. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
    Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9 PMID: 16849428
  148. DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML.
    Curr Pharm Biotechnol. 2006 Oct;7(5):315-21 PMID: 17076647
  149. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.
    Nature. 2003 Sep 18;425(6955):307-11 PMID: 13679920
  150. The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.
    Cancer Biol Ther. 2005 Jan;4(1):70-6 PMID: 15662133
  151. Statin effects on cholesterol micro-domains in brain plasma membranes.
    Biochem Pharmacol. 2003 Mar 1;65(5):843-56 PMID: 12628479
  152. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.
    J Clin Invest. 2000 Dec;106(11):1331-9 PMID: 11104786
  153. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
    Exp Cell Res. 2005 Aug 15;308(2):241-53 PMID: 15921680
  154. Cancer and the chemokine network.
    Nat Rev Cancer. 2004 Jul;4(7):540-50 PMID: 15229479
  155. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.
    Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6 PMID: 14711994
  156. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule.
    J Clin Invest. 2003 Jul;112(1):42-9 PMID: 12824456
  157. Prospective identification of tumorigenic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 PMID: 12629218
  158. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
    Nature. 1996 Aug 15;382(6592):635-8 PMID: 8757135
  159. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines.
    Cancer Lett. 2007 Sep 18;255(1):153-9 PMID: 17532557
  160. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  161. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Clin Cancer Res. 2005 Mar 1;11(5):1835-41 PMID: 15756007
  162. The stem-cell niche as an entity of action.
    Nature. 2006 Jun 29;441(7097):1075-9 PMID: 16810242
  163. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.
    Cancer Cell. 2004 Nov;6(5):459-69 PMID: 15542430
  164. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.
    Proc Natl Acad Sci U S A. 2005 May 10;102(19):6942-7 PMID: 15860580
  165. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Cancer Res. 2006 Jan 1;66(1):46-51 PMID: 16397214
  166. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.
    Cancer Res. 2004 Nov 15;64(22):8420-7 PMID: 15548713
  167. Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies.
    Leukemia. 2004 Jan;18(1):1-10 PMID: 14574330
  168. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Prostate. 2006 Jan 1;66(1):32-48 PMID: 16114056
  169. Chemokines, chemokine receptors, and cancer metastasis.
    J Leukoc Biol. 2006 Apr;79(4):639-51 PMID: 16478915
  170. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Cancer Res. 2005 Mar 1;65(5):1800-7 PMID: 15753377
  171. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
    J Clin Endocrinol Metab. 2003 Jan;88(1):408-16 PMID: 12519884
  172. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4.
    Proc Natl Acad Sci U S A. 2006 May 23;103(21):8221-6 PMID: 16702540
  173. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
    Breast Cancer Res. 2008;10 (1):R10 PMID: 18241344
  174. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Cell. 2005 May 6;121(3):335-48 PMID: 15882617
  175. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Cancer Res. 2005 Jan 15;65(2):465-72 PMID: 15695388
  176. Role of CXCL12 in metastasis of human ovarian cancer.
    Chin Med J (Engl). 2007 Jul 20;120(14):1251-5 PMID: 17697577
  177. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
    Cancer Res. 2002 Mar 15;62(6):1832-7 PMID: 11912162
Article Info
Journal
Journal of endocrinological investigation
Abbr.
J Endocrinol Invest
ISSN
1720-8386
Published
2008-09-00
Pages
809-19
Language
English
Region
Italy
NLM ID
7806594
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com